[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 55,654
Sort by:

Waldenstrom Macroglobulinemia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF WALDENSTROM MACROGLOBULINEMIA PIPELINE REPORT INCLUDES Panorama of Waldenstrom Macroglobulinemia pipeline markets including statistics on therapeutic drugs and companies involved Waldenstrom Macroglobulinemia Pipeline candidates across various development ...

August 2018 160 pages

Wegener Polyangiitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF WEGENER POLYANGIITIS PIPELINE REPORT INCLUDES Panorama of Wegener Polyangiitis pipeline markets including statistics on therapeutic drugs and companies involved Wegener Polyangiitis Pipeline candidates across various development ...

August 2018 50 pages

West Nile Virus Infections R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF WEST NILE VIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of West Nile Virus Infections pipeline markets including statistics on therapeutic drugs and companies involved West Nile Virus Infections Pipeline candidates across ...

August 2018 50 pages

Western Equine Encephalitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF WESTERN EQUINE ENCEPHALITIS PIPELINE REPORT INCLUDES Panorama of Western Equine Encephalitis pipeline markets including statistics on therapeutic drugs and companies involved Western Equine Encephalitis Pipeline candidates across various development ...

August 2018 20 pages

Wilson Disease R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF WILSON DISEASE PIPELINE REPORT INCLUDES Panorama of Wilson Disease pipeline markets including statistics on therapeutic drugs and companies involved Wilson Disease Pipeline candidates across various development ...

August 2018 40 pages

Women Infertility R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF WOMEN INFERTILITY PIPELINE REPORT INCLUDES Panorama of Women Infertility pipeline markets including statistics on therapeutic drugs and companies involved Women Infertility Pipeline candidates across various development ...

August 2018 150 pages

Xerostomia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF XEROSTOMIA PIPELINE REPORT INCLUDES Panorama of Xerostomia pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Yellow Fever R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF YELLOW FEVER PIPELINE REPORT INCLUDES Panorama of Yellow Fever pipeline markets including statistics on therapeutic drugs and companies involved Yellow Fever Pipeline candidates across various development ...

August 2018 40 pages

Aspergillosis Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Aspergillosis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Aspergillosis pipeline products. DISEASE OVERVIEW Aspergillus is a general fungus type that causes ...

August 2018 90 pages

Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

... is the main challenge in detecting and treating Burkholderia Infections disease. Individuals with low immunity levels and ... Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Burkholderia ...

August 2018 45 pages

Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Chagas Disease (American trypanosomiasis) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chagas Disease (American trypanosomiasis) pipeline products. DISEASE OVERVIEW Chagas disease, also known as American Trypanosomiasis, is one of the ...

August 2018 70 pages

Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chikungunya (CHIKV) Infection pipeline products. DISEASE OVERVIEW Chikungunya fever is a viral fever, caused ...

August 2018 90 pages

Chlamydia Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Chlamydia Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Chlamydia pipeline products. DISEASE OVERVIEW Chlamydia infections are caused by Chlamydia trachomatis bacteria. Worldwide, the ...

August 2018 60 pages

Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Cryptosporidiosis (crypto) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptosporidiosis (crypto) pipeline products. DISEASE OVERVIEW Cryptosporidium is one of the most widespread intestinal ...

August 2018 30 pages

Diphtheria Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Diphtheria Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Diphtheria pipeline products. DISEASE OVERVIEW Global Diphtheria market is estimated to be around $4.5 billion in 2020 driven ...

August 2018 60 pages

Haemophilus influenza (Hib)- Type B Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

... disease publication with comprehensive information of Haemophilus influenza (Hib) Infection pipeline products. DISEASE OVERVIEW Haemophilus influenza bacteria (Hib) often causes various types of infections ranging from mild ...

August 2018 60 pages

Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Hepatitis A (HAV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis A (HAV) Infection pipeline products. DISEASE OVERVIEW The disease is primarily ...

August 2018 35 pages

Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Hepatitis D (HDV) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Hepatitis D (HDV) pipeline products. DISEASE OVERVIEW Hepatitis D virus (HDV) infection is a liver disease ...

August 2018 50 pages

Herpes Labialis Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Herpes Labialis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Herpes Labialis pipeline products. DISEASE OVERVIEW Herpes Labialis referred to as cold sores, is a widespread infection impacting ...

August 2018 35 pages

Human Parainfluenza Virus 3 (HPIV-3) Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

... . SCOPE OF HUMAN PARAINFLUENZA VIRUS 3 (HPIV-3) INFECTION PIPELINE REPORT INCLUDES Panorama of Human Parainfluenza Virus 3 (HPIV-3) Infection pipeline markets including statistics on therapeutic drugs and companies involved Human Parainfluenza Virus 3 (HPIV-3) Infection Pipeline ...

August 2018 30 pages

Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Japanese Encephalitis (JEV) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Japanese Encephalitis (JEV) Infection pipeline products. DISEASE OVERVIEW Japanese encephalitis virus or JAVEX is a viral ...

August 2018 40 pages

Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Klebsiella pneumoniae pipeline products. DISEASE OVERVIEW Klebsiella pneumoniae belongs to the class of Gram-negative bacteria ...

August 2018 90 pages

Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Leishmaniasis (Kala-azar) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Leishmaniasis (Kala-azar) pipeline products. DISEASE OVERVIEW Leishmaniasis is one of the most researched areas among ...

August 2018 90 pages

Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Meningococcus (Neisseria meningitidis Infection) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Meningococcus (Neisseria meningitidis Infection) pipeline products. DISEASE OVERVIEW Meningococcal infection is one of the ...

August 2018 65 pages

Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Progressive Multifocal Leukoencephalopathy (PML) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Progressive Multifocal Leukoencephalopathy (PML) pipeline products. DISEASE OVERVIEW Progressive multifocal leukoencephalopathy (PML) is a ...

August 2018 35 pages

Q-Fever (Query Fever) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

... . SCOPE OF Q-FEVER (QUERY FEVER) PIPELINE REPORT INCLUDES Panorama of Q-Fever (Query Fever) pipeline markets including statistics on therapeutic drugs and companies involved Q-Fever (Query Fever) Pipeline candidates across various development phases ...

August 2018 30 pages

Rabies Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Rabies Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rabies pipeline products. DISEASE OVERVIEW Human rabies is rare but fatal disease causing 50,000 ...

August 2018 60 pages

Rotavirus Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Rotavirus Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rotavirus pipeline products. DISEASE OVERVIEW Rotavirus virus symptoms include diarrhea, nausea and stomach ...

August 2018 45 pages

Rubella (German measles) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Rubella (German measles) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rubella (German measles) pipeline products. DISEASE OVERVIEW Rubella virus is one of the key ...

August 2018 30 pages

Tetanus Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Tetanus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tetanus Infection pipeline products. DISEASE OVERVIEW Tetanus infection is spread through Clostridium tetani bacteria, which ...

August 2018 65 pages

Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Tularaemia (Rabbit Fever) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Tularaemia (Rabbit Fever) pipeline products. DISEASE OVERVIEW Tularaemia or Francisella tularensis infection or Rabbit Fever is a catastrophic ...

August 2018 35 pages

Vancomycin Resistant Enterococcal (VRE) Infection Drug Development Pipeline Study, H2 2018

US$ 1,200.00

... use format. SCOPE OF VANCOMYCIN RESISTANT ENTEROCOCCAL (VRE) INFECTION PIPELINE REPORT INCLUDES Panorama of Vancomycin Resistant Enterococcal (VRE) Infection pipeline markets including statistics on therapeutic drugs and companies involved Vancomycin Resistant Enterococcal (VRE) Infection Pipeline candidates ...

August 2018 70 pages

Yellow Fever Drug Development Pipeline Study, H2 2018

US$ 1,200.00

Yellow Fever Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Yellow Fever pipeline products. DISEASE OVERVIEW Yellow fever is a mosquito-borne infection that ranges from ...

August 2018 40 pages

2018 and Beyond: Australia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Australia and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Australia pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Austria Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Austria and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Austria pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Belgium Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Belgium and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Belgium pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Bulgaria Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Bulgaria and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Bulgaria pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Canada Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Canada and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Canada pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Chile Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Chile and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Chile pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Croatia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Croatia and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Croatia pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Cyprus Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Cyprus and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Cyprus pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Czech Republic Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... is also provided for the country. The research study on Czech Republic healthcare spending provides outlook of total spending, government expenditure, ... ongoing research studies. The report also considers the Czech Republic healthcare industry prospects and infrastructure detailing hospitals, physicians, ...

July 2018 120 pages

2018 and Beyond: Denmark Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Denmark and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Denmark pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Estonia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Estonia and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Estonia pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Finland Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Finland and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Finland pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: France Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in France and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of France pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Germany Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Germany and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Germany pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Greece Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Greece and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Greece pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Hungary Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Hungary and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Hungary pharmaceutical market insights and outlook.

July 2018 120 pages

2018 and Beyond: Iceland Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025

US$ 2,000.00

... to long term future. This report focuses its attention on pharmaceutical market in Iceland and presents market trends, drivers and challenges facing the ... are presented in ready to use format, which enables ease of understanding of Iceland pharmaceutical market insights and outlook.

July 2018 120 pages

Filters

Search

Categories

12,968
1,223
4,429
2
1
8,271
2,818
15,138
67
8,921
1
1,229
586

Publishers

55,654

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
55,617

Price

Date

Pages

Offers